ClinicalTrialsFinder

IKZF1 Gene Mutation Clinical Trials in Guangzhou, Guangdong

1 recruitingGuangzhou, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL

Acute Lymphoblastic LeukemiaAdult ALLPhiladelphia-Positive ALL+2 more
Nanfang Hospital, Southern Medical University67 enrolled1 locationNCT06220487